首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺良,恶性病变Ki67单克隆抗体标记观察
引用本文:张树华 吴照敏. 乳腺良,恶性病变Ki67单克隆抗体标记观察[J]. 临床与实验病理学杂志, 1994, 10(4): 293-295,T001
作者姓名:张树华 吴照敏
作者单位:滨州医学院病理学教研室,滨州医学院病理学教研室,滨州医学院病理学教研室,滨州医学院病理学教研室 山东 256603,山东 256603,山东 256603,山东 256603
摘    要:本文用Ki67单克隆抗体对11例乳腺浸润性导管癌、10例乳腺良性病变做了研究。结果显示乳癌Ki67标记阳性率较高(M12.5),良性病变较低(M8.15),两者间差异有显著性(P=0.05)。乳癌Ki67 记阳性率与核分裂计数和核面积呈显著正相关(相关系数分别为0.849,P<0.01和0.740,P<0.01)。未发现与淋巴结转移,肿物大小和年龄之间的相关性(P>0.05)。

关 键 词:乳腺癌 Ki67 免疫组织化学 抗体 乳腺疾病

Study of Ki67 Immunostaining in Benign and Malignant Breast Lesions
Zhang Shuhua,Wu Zhaomin,Li Baowen et al. Study of Ki67 Immunostaining in Benign and Malignant Breast Lesions[J]. Chinese Journal of Clinical and Experimental Pathology, 1994, 10(4): 293-295,T001
Authors:Zhang Shuhua  Wu Zhaomin  Li Baowen et al
Abstract:Eleven cases of infiltrating duct carcinoma of breast and 10 cases of benignbreast lesions were studied by immuostain-ing with monoclonal antibody Ki67. The re- suits showed that Ki67 labeling rates of breast carcinoma were higher ( Median 12-5), benign lesions lower (Median 8- 15) , there was a significant difference between them (P = 0. 05). The Ki67 labeling rates of breast carcinoma were related to mitotic count and nuclear area (r=0. 849,P <0. 01; r=0. 740, P<0. 01 respectively).There was not relation-ship between Ki67 labeling rates of breast carcinoma, lymph node involvement, tumor in diameter, and age (P>0. 05).
Keywords:breast lesions  breast carcino-ma  Ki67  immunohistochemistry  mitotic count  morphometry
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号